Gradient Investments’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Gradient Investments’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12	Closed	–	–	1289
2019 Q4	$0	Hold	12	–	–	﹤0.01%	1280
2019 Q3	$0	Hold	12	–	–	﹤0.01%	1273
2019 Q2	$0	Sell	12 -1	-8%	-$8	﹤0.01%	1097
2019 Q1	$0	Hold	13	–	–	﹤0.01%	1040
2018 Q4	$0	Hold	13	–	–	﹤0.01%	1126
2018 Q3	$0	Hold	13	–	–	﹤0.01%	1096
2018 Q2	$0	Hold	13	–	–	﹤0.01%	1176
2018 Q1	$0	Hold	13	–	–	﹤0.01%	1209
2017 Q4	$1K	Buy	+13	New	+$583	﹤0.01%	977
2017 Q3	–	Sell	-13	Closed	-$2K	–	764
2017 Q2	$2K	Buy	+13	New	+$2.28K	﹤0.01%	702

Other funds holding SIOX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gradient Investments's SIOX Position: Q1 2020 in Review

Gradient Investments sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2020, closing a stake of 12 shares.

Gradient Investments first reported a position in SIOX in Q2 2017 and held it in 10 quarters. The position peaked at $2K in Q2 2017. 42 funds tracked by Wall St. Rank hold SIOX as of Q1 2020.

Gradient Investments reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Gradient Investments sold 12 Sio Gene Therapies Inc. Common Stock shares in Q1 2020.
Gradient Investments first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2017 and held it in 10 quarters.
Gradient Investments's Sio Gene Therapies Inc. Common Stock position peaked at $2K in Q2 2017.
42 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2020.

Based on Gradient Investments's 13F filing for Q1 2020, filed 7 Apr 2020.